DrugDev Continues the Conversation of Improving Clinical Trials Using Innovative Technology at Global Pharmaceutical Conferences in July
Executive Chairman and Principal Investigator Hugo Stephenson MD and colleagues to promote the benefits of industry-wide collaboration, standardization and a beautiful technology experience
KING OF PRUSSIA, PA (PRWEB) July 08, 2016
DrugDev will participate in the following industry conferences this month:
AsiaPac Site Solutions Summit, July 14-15, Melbourne, Australia – Hugo Stephenson MD, Executive Chairman of DrugDev and Principal Investigator, will extend a warm Aussie welcome to Christine Pierre, President of the Society for Clinical Research Sites (SCRS) as she kicks off the conference. To schedule a meeting with Hugo, email DrugDev at solutions(at)drugdev(dot)com. For more information on the conference visit http://apsitesolutionssummit.com
Clinical Operations in Oncology Trials Conference, July 13-14, Boston, Mass. – DrugDev is a conference sponsor and will showcase our unified platform at Booth #1. Stop by, or contact us at solutions(at)drugdev(dot)com to arrange a personal appointment. For more information on the conference visit http://www.arena-international.com/oncologyusa
DrugDev’s unified clinical suite enables sponsors, CROs and sites to do more trials through industry-wide collaboration, standardization and a beautiful technology experience. Featuring solutions for global site payments, site identification and activation, workflow optimization, learning management, and site and patient engagement, DrugDev helps companies transform the quality and efficiency of clinical trials from startup through closeout. The company also powers the revolutionary TransCelerate Investigator Registry and Investigator Databank collaborations with the universal identifier known as the DrugDev Golden Number. Learn why 9 of the top 10 sponsors and 4 of the top 5 CROs trust DrugDev technology at drugdev.com.